Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Silo Pharma (SILO) Gross Profit (2019 - 2025)

Silo Pharma (SILO) has disclosed Gross Profit for 7 consecutive years, with -$2663.0 as the latest value for Q4 2025.

  • Quarterly Gross Profit fell 116.08% to -$2663.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $27807.0 through Dec 2025, down 58.04% year-over-year, with the annual reading at $27807.0 for FY2025, 58.04% down from the prior year.
  • Gross Profit hit -$2663.0 in Q4 2025 for Silo Pharma, roughly flat from -$2662.0 in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $16566.0 in Q2 2021 to a low of -$2663.0 in Q4 2025.
  • Historically, Gross Profit has averaged $14643.0 across 5 years, with a median of $16566.0 in 2021.
  • Biggest five-year swings in Gross Profit: soared 7787.14% in 2021 and later plummeted 116.08% in 2025.
  • Year by year, Gross Profit stood at $16566.0 in 2021, then changed by 0.0% to $16566.0 in 2022, then changed by 0.0% to $16566.0 in 2023, then changed by 0.0% to $16566.0 in 2024, then crashed by 116.08% to -$2663.0 in 2025.
  • Business Quant data shows Gross Profit for SILO at -$2663.0 in Q4 2025, -$2662.0 in Q3 2025, and $16566.0 in Q2 2025.